Evidence map›Paper›PMID 33332170›Full record

ArticleJCO oncology practice2021

Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California.

Julie Tsu-Yu Wu, Daniel H Kwon, Michael J Glover, Solomon Henry, Douglas Wood, Daniel L Rubin, Vadim S Koshkin, Lidia Schapira, Sumit A Shah

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05130710 (The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05130710 completednot on this map

The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer

TypeobservationalSponsorTehran University of Medical SciencesRan2020 to 2021Enrolled80ConditionsGastric Cancer, COVID-19 Pandemic, Peritoneal MetastasesArmsstaging laparoscopy
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Child Abuse and the COVID-19 Pandemic.The Journal of surgical research · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Julie Tsu-Yu WuDepartment of Medical Oncology, Stanford University, Stanford, CA.ORCID https://orcid.org/0000-0003-2388-1827
Daniel H KwonDepartment of Medical Oncology, University of California, San Francisco, San Francisco, CA.ORCID https://orcid.org/0000-0002-0830-7918
Michael J GloverDepartment of Internal Medicine, Stanford University, Stanford, CA.
Solomon HenryDepartment of Biomedical Data Science, Stanford University, Stanford, CA.ORCID https://orcid.org/0000-0003-1591-1897
Douglas WoodDepartment of Biomedical Data Science, Stanford University, Stanford, CA.ORCID https://orcid.org/0000-0002-4332-9696
Daniel L RubinDepartment of Biomedical Data Science, Stanford University, Stanford, CA.ORCID https://orcid.org/0000-0001-5057-4369
Vadim S KoshkinDepartment of Medical Oncology, University of California, San Francisco, San Francisco, CA.
Lidia SchapiraDepartment of Medical Oncology, Stanford University, Stanford, CA.
Sumit A ShahDepartment of Medical Oncology, Stanford University, Stanford, CA.
Stanford University · USUniversity of California, San Francisco · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
6 · The paper itself

Abstract

purposeThe response to the COVID-19 pandemic has affected the management of patients with cancer. In this pooled retrospective analysis, we describe changes in management patterns for patients with cancer diagnosed with COVID-19 in two academic institutions in the San Francisco Bay Area. MATERIALS AND

methodsAdult and pediatric patients diagnosed with COVID-19 with a current or historical diagnosis of malignancy were identified from the electronic medical record at the University of California, San Francisco, and Stanford University. The proportion of patients undergoing active cancer management whose care was affected was quantified and analyzed for significant differences with regard to management type, treatment intent, and the time of COVID-19 diagnosis. The duration and characteristics of such changes were compared across subgroups.

resultsA total of 131 patients were included, of whom 55 were undergoing active cancer management. Of these, 35 of 55 (64%) had significant changes in management that consisted primarily of delays. An additional three patients not undergoing active cancer management experienced a delay in management after being diagnosed with COVID-19. The decision to change management was correlated with the time of COVID-19 diagnosis, with more delays identified in patients treated with palliative intent earlier in the course of the pandemic (March/April 2020) compared with later (May/June 2020) (OR, 4.2; 95% CI, 1.03 to 17.3;

conclusionWe found significant changes in the management of cancer patients with COVID-19 treated with curative and palliative intent that evolved over time. Future studies are needed to determine the impact of changes in management and treatment on cancer outcomes for patients with cancer and COVID-19.

Indexed as

Administration, OralAdolescentAdultAgedAged, 80 and overAntineoplastic AgentsCaliforniaChildChild, PreschoolCOVID-19FemaleHumansInfusions, IntravenousInjections, IntramuscularMaleMiddle AgedAntineoplastic Agents

Identifiers

PMID33332170
PMCPMC8462649
OpenAlexW3112425050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.